MGMT promoter methylation and field defect in sporadic colorectal cancer. - Wikidata - wikimedia - TriplyDB

MGMT promoter methylation and field defect in sporadic colorectal cancer.

MGMT promoter methylation and field defect in sporadic colorectal cancer.

http://www.wikidata.org/entity/Q34452509

about

Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer Epigenetic field defects in progression to cancer MicroRNA-124a and microRNA-34b/c are frequently methylated in all histological types of colorectal cancer and polyps, and in the adjacent normal mucosa Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesis Field defects in progression to gastrointestinal tract cancers Gut Microbiota Imbalance and Base Excision Repair Dynamics in Colon Cancer MicroRNAs as diagnostic and prognostic biomarkers in colorectal cancer The clinical value of aberrant epigenetic changes of DNA damage repair genes in human cancer Etiologic field effect: reappraisal of the field effect concept in cancer predisposition and progression Toward a Molecular Classification of Colorectal Cancer: The Role of MGMT Field cancerisation in colorectal cancer: a new frontier or pastures past?Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer Promoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associated with adenoma-carcinoma sequence Cancer stem cells: the lessons from pre-cancerous stem cells Epigenetic reduction of DNA repair in progression to gastrointestinal cancer Biomarkers of genome instability and cancer epigenetics.Analysis of fecal DNA methylation to detect gastrointestinal neoplasia.Patterns of DNA methylation in the normal colon vary by anatomical location, gender, and age Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer.Alcohol induces cell proliferation via hypermethylation of ADHFE1 in colorectal cancer cells.Epigenetic alterations in RASSF1A in human aberrant crypt foci Alteration of proliferation and apoptotic markers in normal and premalignant tissue associated with prostate cancer Clinical implications and utility of field cancerization Activity of temozolomide in patients with advanced chemorefractory colorectal cancer and MGMT promoter methylation.Aberrant gene promoter methylation associated with sporadic multiple colorectal cancer Quantitative methylation profiling in tumor and matched morphologically normal tissues from breast cancer patients Methylation-sensitive enrichment of minor DNA alleles using a double-strand DNA-specific nuclease.Spatially resolved optical and ultrastructural properties of colorectal and pancreatic field carcinogenesis observed by inverse spectroscopic optical coherence tomography DNA methylation in the rectal mucosa is associated with crypt proliferation and fecal short-chain fatty acids.New insights into the molecular pathogenesis of colorectal cancer.Colorectal advanced neoplasms occur through dual carcinogenesis pathways in individuals with coexisting serrated polyps.Thrombospondin-4 is a putative tumour-suppressor gene in colorectal cancer that exhibits age-related methylation Analysis of the DNA methylation level of cancer-related genes in colorectal cancer and the surrounding normal mucosa.MGMT promoter hypermethylation and K-RAS, PTEN and TP53 mutations in tamoxifen-exposed and non-exposed endometrial cancer cases Methylation pattern of the O6-methylguanine-DNA methyltransferase gene in colon during progressive colorectal tumorigenesis.Piwil2 expressed in various stages of cervical neoplasia is a potential complementary marker for p16 O6-Methylguanine-DNA methyltransferase protein expression by immunohistochemistry in brain and non-brain systemic tumours: systematic review and meta-analysis of correlation with methylation-specific polymerase chain reaction.A prospective cohort study shows unique epigenetic, genetic, and prognostic features of synchronous colorectal cancers.Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma.Interplay between epigenetics and metabolism in oncogenesis: mechanisms and therapeutic approaches

P2860

Q21245721-9AFB9AE6-85D9-4BCD-AA75-A9FB38485CB3 Q22241089-05937098-27E4-416D-8BBC-9347452F0EC2 Q24623009-3FB5CB2D-E5EA-452D-A59F-3AF030B984A4 Q24631440-8525EEF6-AE04-4D02-BB70-134D4C33E244 Q24653877-6F381FC2-09CE-4EC3-9A8A-253F52F27009 Q26740627-16656706-C29C-492F-A7C5-690E4E76BE50 Q26751780-46C1FC90-40EC-498E-8658-032A8743FF74 Q26766285-F0B8B34C-3593-41F2-8EB9-B0A9EB1D1B4E Q26852716-613A1C5F-010F-4649-89B1-3B18F5029B39 Q26862363-75E33AEA-1523-4EF0-A51F-C4DE236AE4CD Q26862851-39DE31AD-5E41-4BF7-B6F2-4CD076DFFFDA Q28239338-7EE11872-EE89-423F-8ADA-554DDADD0A66 Q28241736-76922A43-85D4-4EAE-A5AC-1E634E6834CA Q28259527-DA583442-864D-43BE-B855-A876CE0E7209 Q28262162-A0FC0995-945C-4BC3-B5B6-2C723F26F815 Q30248745-C506B9C6-BED0-47CA-8FA6-179CF65D3CC5 Q30491000-37812EDE-9E98-49C0-9409-59C0E05B58BE Q30585819-40D367C5-6D4F-4D28-9E1A-A5026CF15D4E Q30981767-FE74445C-E263-4125-91B7-FDFC35E00E94 Q31162259-169DF784-A912-4E1A-8FAB-3F60AB00369B Q33235330-100FD487-9988-49BE-A464-59E10D33362C Q33236893-14D11579-3232-4F58-B8FC-CDC94FABB7E1 Q33278836-ED91FE9B-502D-4FD6-B90C-13F81C6A2BCD Q33412380-5824DCB0-169F-4EF7-9B9F-084A1CBF591C Q33526369-638DB52B-42EC-405E-9BA0-BC50F8A16F86 Q33540332-86BBE359-CB5A-43A4-83C4-4830D436A545 Q33557917-E03DA3E9-B178-4831-BA98-6C2C08FE5A0B Q33604116-7FE3D028-96CA-4DC7-B010-513472848F85 Q33634174-7DA39077-2EE7-450B-8222-B84B994B5B8C Q33640592-C35F4666-86D9-4B30-AC0F-6425D8B42019 Q33645406-79EFD01E-7B87-4DEC-B8C5-CBB1FC0F90B3 Q33693866-E2AB2B2F-4AE6-4665-9CC4-55CBB04F0A70 Q33706656-9A0C096B-022B-49D3-9963-33961CE3C7D3 Q33750187-A4DFDF50-05C8-408A-B60E-BC31C3C9CA8E Q33775531-05CC4114-0D0D-43C1-861C-A7CDFED05EFD Q33793496-7F5374A6-6D48-411A-9B59-68FC314D63FD Q33804528-D0167B50-19AA-41F0-9761-D718AD20E8C1 Q33808550-9144519A-A715-4803-8763-2ECCE534C10D Q33831996-12DCC916-A20B-474F-AF47-E29FEDED8765 Q33835913-D55C114B-C57F-4597-A035-9E17CE0F0AAF

P2860

MGMT promoter methylation and field defect in sporadic colorectal cancer.

http://www.wikidata.org/entity/Q34452509

description

2005 nî lūn-bûn

@nan

2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

MGMT promoter methylation and field defect in sporadic colorectal cancer.

@ast

MGMT promoter methylation and field defect in sporadic colorectal cancer.

@en

MGMT promoter methylation and field defect in sporadic colorectal cancer.

@nl

type

label

MGMT promoter methylation and field defect in sporadic colorectal cancer.

@ast

MGMT promoter methylation and field defect in sporadic colorectal cancer.

@en

MGMT promoter methylation and field defect in sporadic colorectal cancer.

@nl

prefLabel

MGMT promoter methylation and field defect in sporadic colorectal cancer.

@ast

MGMT promoter methylation and field defect in sporadic colorectal cancer.

@en

MGMT promoter methylation and field defect in sporadic colorectal cancer.

@nl

P1433

Q34452509-1A2D9A9B-4477-4554-8CC9-05660C70397E

P1476

Q34452509-69B73A94-43FD-4567-9D1A-B368835E4853

P2093

Q34452509-03042E55-0DEA-425D-9572-36F49AE6DD2F

Q34452509-0C05F317-2F2B-4A48-8278-3B2E56D71E55

Q34452509-132EF4AC-6E81-44E5-AFD5-E716EF23C224

Q34452509-22FC19AE-185B-4FB1-AD77-1D9BFFD222D3

Q34452509-39FE87FD-11A6-45B0-9ED5-CDAABA7B9671

Q34452509-3C3B5E04-EDE5-4B8C-A7BD-96D540DCD82D

Q34452509-4488802B-E041-4899-A11D-A34B06A6FDB1

Q34452509-90BA5B6B-D37B-4E9E-9280-BF8064DF4F0F

Q34452509-AC6AFD23-1A67-4A1B-8970-1689E99316FB

Q34452509-AE1A835F-E287-4712-9D6F-55C5DB2DB5C8

P2860

Q34452509-0F57AD6A-2428-47F4-9BB6-2804CC487414

Q34452509-1AEFAB2D-CF48-4809-B3EA-9AE5DBBBE39B

Q34452509-290B06EC-5078-446B-B48E-49F9852296A3

Q34452509-31D27324-8E74-48F8-842C-3620326E6BD9

Q34452509-5574339A-6BEA-4B41-A5E4-C7306AE4372D

Q34452509-64E7F4BB-C95E-4080-9F87-53E63ED4C379

Q34452509-6BD15099-395B-4026-B080-F26F55B2D4B1

Q34452509-7FB0A4A8-E20E-485C-AAE6-11BFB01ACB4F

Q34452509-9CD5FF20-1566-4C6B-A199-67B5353116E1

Q34452509-A1F824D5-18E5-4C51-93DA-C475DC8C5DF3

P304

Q34452509-6C14844A-3E40-4EEB-B12D-AFCA136318B7

P31

Q34452509-1D7EB874-9FCC-4AAE-A1E1-4E51A3C694B6

P356

Q34452509-90E5DB0F-8AAC-4029-B31F-DB4DBB9C9E75

P407

Q34452509-79B031B0-C1A1-40F5-BC1C-0ACFDCC2E0BC

P433

Q34452509-A39AFD5B-A09E-44B1-BC1F-CFF364F69A18

P478

Q34452509-E005A8ED-590A-43ED-93D9-B050241F3020

P50

Q34452509-D964D413-97CC-415D-8F77-800DFF1E4E14

P577

Q34452509-3DF211BB-C38C-42C9-9DAE-351527C9A8BC

P5875

Q34452509-98AE7AA1-BFD8-4FE4-A719-CFAE19182462

P698

Q34452509-9EBC8D48-B1CF-4115-A289-F8F0AAEEFC28

P921

Q34452509-4E793B95-E838-41BE-960E-50D15915053C

P356

P1433

Journal of the National Cancer Institute

P1476

MGMT promoter methylation and field defect in sporadic colorectal cancer

@en

P2093

Anil R Prasad

http://www.w3.org/2001/XMLSchema#string

David S Alberts

http://www.w3.org/2001/XMLSchema#string

Gary L Rosner

http://www.w3.org/2001/XMLSchema#string

Janine G Einspahr

http://www.w3.org/2001/XMLSchema#string

Jill Vilaythong

http://www.w3.org/2001/XMLSchema#string

Julie Buckmeier

http://www.w3.org/2001/XMLSchema#string

Lanlan Shen

http://www.w3.org/2001/XMLSchema#string

Lianchun Xiao

http://www.w3.org/2001/XMLSchema#string

Natalie Supunpong Hernandez

http://www.w3.org/2001/XMLSchema#string

P Scott Houlihan

http://www.w3.org/2001/XMLSchema#string

P2860

High sensitivity mapping of methylated cytosines

CpG island methylator phenotype in colorectal cancer

Cancer epigenetics comes of age

Emerging molecular markers of cancer.

Variability and regulation of O6-alkylguanine-DNA alkyltransferase.

BER, MGMT, and MMR in defense against alkylation-induced genotoxicity and apoptosis.

Colorectal cancer screening: clinical guidelines and rationale.

Chemoprevention of aerodigestive tract cancers.

Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype

Sensitive detection of DNA methylation.

P304

1330-1338

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/DJI275

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

97

http://www.w3.org/2001/XMLSchema#string

P50

Jean-Pierre J Issa

P577

2005-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7588773

http://www.w3.org/2001/XMLSchema#string

P698

16174854

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer